These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 22643325)

  • 1. Impaired contractility and detrusor hypertrophy in cavin-1-deficient mice.
    Karbalaei MS; Rippe C; Albinsson S; Ekman M; Mansten A; Uvelius B; Swärd K
    Eur J Pharmacol; 2012 Aug; 689(1-3):179-85. PubMed ID: 22643325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomechanical properties and innervation of the female caveolin-1-deficient detrusor.
    Sadegh MK; Ekman M; Rippe C; Sundler F; Wierup N; Mori M; Uvelius B; Swärd K
    Br J Pharmacol; 2011 Mar; 162(5):1156-70. PubMed ID: 21091642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cavin-3 (PRKCDBP) deficiency reduces the density of caveolae in smooth muscle.
    Zhu B; Swärd K; Ekman M; Uvelius B; Rippe C
    Cell Tissue Res; 2017 Jun; 368(3):591-602. PubMed ID: 28285351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations in caveolin expression and ultrastructure after bladder smooth muscle hypertrophy.
    Polyák E; Boopathi E; Mohanan S; Deng M; Zderic SA; Wein AJ; Chacko S
    J Urol; 2009 Nov; 182(5):2497-503. PubMed ID: 19765744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of bladder smooth muscle caveolae in the aging bladder.
    Lowalekar SK; Cristofaro V; Radisavljevic ZM; Yalla SV; Sullivan MP
    Neurourol Urodyn; 2012 Apr; 31(4):586-92. PubMed ID: 22374691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arterial dysfunction but maintained systemic blood pressure in cavin-1-deficient mice.
    Swärd K; Albinsson S; Rippe C
    PLoS One; 2014; 9(3):e92428. PubMed ID: 24658465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemical and functional correlates of an increased membrane density of caveolae in hypertrophic rat urinary bladder.
    Shakirova Y; Swärd K; Uvelius B; Ekman M
    Eur J Pharmacol; 2010 Dec; 649(1-3):362-8. PubMed ID: 20868660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Similar regulatory mechanisms of caveolins and cavins by myocardin family coactivators in arterial and bladder smooth muscle.
    Zhu B; Rippe C; Thi Hien T; Zeng J; Albinsson S; Stenkula KG; Uvelius B; Swärd K
    PLoS One; 2017; 12(5):e0176759. PubMed ID: 28542204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urogenital alterations in aged male caveolin-1 knockout mice.
    Woodman SE; Cheung MW; Tarr M; North AC; Schubert W; Lagaud G; Marks CB; Russell RG; Hassan GS; Factor SM; Christ GJ; Lisanti MP
    J Urol; 2004 Feb; 171(2 Pt 1):950-7. PubMed ID: 14713860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using caveolin-1 knockout mouse to study impaired detrusor contractility and disrupted muscarinic activity in the aging bladder.
    Lai HH; Boone TB; Thompson TC; Smith CP; Somogyi GT
    Urology; 2007 Feb; 69(2):407-11. PubMed ID: 17320698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen and postnatal maturation increase caveolar number and caveolin-1 protein in bladder smooth muscle cells.
    Zhu Q; Resnick NM; Elbadawi A; Kuchel GA
    J Urol; 2004 Jan; 171(1):467-71. PubMed ID: 14665957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of caveolin-1 expression is associated with disruption of muscarinic cholinergic activities in the urinary bladder.
    Lai HH; Boone TB; Yang G; Smith CP; Kiss S; Thompson TC; Somogyi GT
    Neurochem Int; 2004 Dec; 45(8):1185-93. PubMed ID: 15380628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regional distribution and molecular interaction of caveolins in bladder smooth muscle.
    Sullivan MP; Cristofaro V; Radisavljevic ZM; Yalla SV
    BJU Int; 2012 Dec; 110(11 Pt C):E1163-72. PubMed ID: 22897417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of ovarian hormones in the pathogenesis of impaired detrusor contractility: evidence in ovariectomized rodents.
    Zhu Q; Ritchie J; Marouf N; Dion SB; Resnick NM; Elbadawi A; Kuchel GA
    J Urol; 2001 Sep; 166(3):1136-41. PubMed ID: 11490312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Smooth muscle caveolae differentially regulate specific agonist induced bladder contractions.
    Cristofaro V; Peters CA; Yalla SV; Sullivan MP
    Neurourol Urodyn; 2007; 26(1):71-80. PubMed ID: 17123298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human urinary bladder smooth muscle is dependent on membrane cholesterol for cholinergic activation.
    Shakirova Y; Mori M; Ekman M; Erjefält J; Uvelius B; Swärd K
    Eur J Pharmacol; 2010 May; 634(1-3):142-8. PubMed ID: 20176011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cavin proteins: New players in the caveolae field.
    Briand N; Dugail I; Le Lay S
    Biochimie; 2011 Jan; 93(1):71-7. PubMed ID: 20363285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term follow-up of TREK-1 KO mice reveals the development of bladder hypertrophy and impaired bladder smooth muscle contractility with age.
    Xie AX; Iguchi N; Malykhina AP
    Am J Physiol Renal Physiol; 2024 Jun; 326(6):F957-F970. PubMed ID: 38601986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Caveolae, caveolin, and cavins: potential targets for the treatment of cardiac disease.
    Das M; Das DK
    Ann Med; 2012 Sep; 44(6):530-41. PubMed ID: 21651441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of caveolin-1 in cardiovascular regulation.
    Rahman A; Swärd K
    Acta Physiol (Oxf); 2009 Feb; 195(2):231-45. PubMed ID: 18826501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.